Biological Activity
SCR-1481B1 (c-Met inhibitor 2) is a potent compound that has activity against cancers dependent upon Met activation and also has activity against cancers as a VEGFR inhibitor.
In Vitro
More details please refer to Patent WO 2009094417 A1.
In Vivo
No in vivo data are provided in the current product source. Contact us for further information.
Target
VEGFR1
References & source
[1]. Robert M. Borzilleri, et al. 4-pyridinone compounds and their use for cancer. WO/2009094417/A1.
Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.
